AuBEX CORPORATION
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 2Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥35 | +6.1% |
| 2025 | ¥33 | +65.0% |
| 2024 | ¥20 | 0.0% |
| 2023 | ¥20 | -20.0% |
| 2022 | ¥25 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥5,315M | ¥5,387M | ¥6,036M | ¥6,015M |
| Gross Profit | ¥1,880M | ¥1,876M | ¥2,294M | ¥2,008M |
| Operating Income | ¥623M | ¥561M | ¥841M | ¥615M |
| Pretax Income | ¥694M | ¥616M | ¥832M | ¥651M |
| Net Income | ¥469M | ¥436M | ¥580M | ¥573M |
| EPS | ¥169.17 | ¥156.80 | ¥209.05 | ¥209.05 |
| Operating Margin | 11.72% | 10.41% | 13.94% | 10.23% |
| Balance Sheet | ||||
| Total Assets | ¥9,328M | ¥9,722M | ¥9,843M | ¥10,165M |
| Total Equity | ¥5,833M | ¥6,257M | ¥6,708M | ¥7,252M |
| Total Liabilities | ¥3,495M | ¥3,465M | ¥3,135M | ¥2,913M |
| Cash | ¥2,476M | ¥2,953M | ¥2,850M | ¥2,627M |
| Interest-bearing Debt | ¥2,197M | ¥1,840M | ¥1,490M | ¥1,523M |
| Equity Ratio | 62.54% | 64.36% | 68.15% | 71.34% |
| D/E Ratio | 0.38 | 0.29 | 0.22 | 0.21 |
| Cash Flow | ||||
| Operating CF | ¥338M | ¥1,055M | ¥637M | ¥329M |
| Investing CF | -¥184M | -¥165M | -¥160M | -¥444M |
| Financing CF | -¥206M | -¥451M | -¥562M | -¥149M |
| Free CF | ¥64M | ¥904M | ¥455M | -¥114M |
| Efficiency | ||||
| ROE | 8.04% | 6.98% | 8.65% | 7.91% |
| ROA | 5.03% | 4.49% | 5.89% | 5.64% |
Latest IR Information
-
Notice Regarding Damage from the August 2026 Chiba Heavy Rain
Core center flooded due to the Chiba heavy rain, operations halted. No human casualties reported at present; impact on performance is being assessed. If a significant impact is identified, it will be disclosed promptly.
Read more -
Financial Guidance for the Fiscal Year Ending March 2027 | Sales ¥6,000 million (YoY -0.3%)
Oxbex has announced its consolidated earnings forecast for the fiscal year ending March 2027, projecting sales of ¥6,000 million, a 0.3% decrease from the previous year. Operating income is expected to decline by 18.8% to ¥500 million, and net income...
Read more -
Notice Regarding the Financial Results of a Non-listed Parent Company, etc.
Read more -
Notice of Results and Conclusion of Share Repurchase via Off-Audit Purchase Transactions (ToSTNeT-3)
Read more -
Notice Regarding Acquisition of Treasury Shares and Off-Auction Purchase Transactions of Treasury Shares (ToSTNeT-3)
Read more
Latest News (5 items)
Company Information
About
AuBEX CORPORATION manufactures and sells nibs and medical equipment in Japan and internationally. The company offers nibs made from chemical fibers, plastics, and other material; medical equipment and components, such as pressure infusion devices and angiography guide wires; and nibs for makeup and cosmetics products. The company was formerly known as Tokyo hat Co., Ltd. and changed its name to AuBEX CORPORATION in 1985. AuBEX CORPORATION was founded in 1892 and is headquartered in Tokyo, Japan.
